eB2BMart

Velakast Sofosbuvir And Velpatasvir Tablets

₹6,000.00 / Bottle

Specification

form
Tablet
brand
Velpas-S
storage
Store Below 25 Degree C
treatment
The Hepatitis C Treatment Drug
shelf life
24 Months
composition
Velpatasvir 100 mg and Sofosbuvir 400 mg
dosage form
Tablet
availability
In Stock
manufacturer
Aprazer Healthcare
medicine type
Allopathic
packaging size
28 Tablets
packaging type
Bottle
Add Quantity
Bottle
Response within 4 hoursFree to enquire

Description

Velpatasvir & Sofosbuvir (Tablet Velakast) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. Velakast Sofosbuvir 400 mg & Velpatasvir 100 mg Indication: Sofosbuvir 400 mg & velpatasvir 100 mg is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors. The combination of sofosbuvir and Velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.

Verify supplier credentials before transacting. Enquiries create leads for the supplier.

Velakast Sofosbuvir And Velpatasvir Tablets - ₹6,000.00 | Chawla Medicos | eB2bMart